Hypothalamic Y2 receptors regulate bone formation

Journal of Clinical Investigation

Volumn 109, Issue 7, 2002, Pages 915-921

  Baldock, Paul A ^a   Sainsbury, Amanda ^a   Couzens, Michelle ^a   Enriquez, Ronaldo F ^a   Thomas, Gethin P ^a   Gardiner, Edith M ^a   Herzog, Herbert ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; LEPTIN RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; CONTROLLED STUDY; HYPOTHALAMUS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; REGULATORY MECHANISM; TRABECULAR BONE;

EID: 0036212496     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214588     Document Type: Article

References (38)

1. The role of neuropeptide Y in the antiobesity action of the obese gene product
2. Classical diabetes models: Past lessons and potential new therapies
3. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y
4. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass
5. Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue
6. Inhibitory effects of central neuropeptide Y on the somatotropic and gonadotropic axes in male rats are independent of adrenal hormones
7. Y-receptor subtypes - How many more?
8. Regional distribution of Y-receptor subtype mRNAs in rat brain
9. Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system
10. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus
11. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropepride-Y-containing neurons of the rat hypothalamic arcuate nucleus
12. Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release
13. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells
14. Bone and preparation of bone sections
15. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss
16. Bone histomorphometry: Standardization of nomenclature, symbols, and units
17. Tartrateresistant acid phosphatase (Acp 5): Identification in diverse human tissues and dendritic cells
18. Expression cloning of a human brain neuropeptide Y Y2 receptor
19. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon
20. Volumes of chick and rat osteoclasts cultured on glass
21. The relationship between the number of nuclei of an osteoclast and its resorptive capability in vitro
22. Chronic central neuropeptide Y infusion in normal rats: Status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia
23. Neuropeptide Y actions on reproductive and endocrine functions
24. Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis
25. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats
26. Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats
27. Thyroid status in the obese syndrome of rats
28. Changes in thyroid hormone and thyrotrophin in the serum and thyroid glands of developing genetically obese male and female Zucker rats
29. Abnormal thyroid hormone deiodination in tissues of ob/ob and db/db obese mice
30. Direct hypothalamo-autonomic connections
31. PYY and NPY: Control of gastric motility via action on Y1 and Y2 receptors in the DVC
32. Neuropeptide Y induces fasted pattern of duodenal motility via Y(2) receptors in conscious fed rats
33. Inhibition of vagal vasodilatation by a selective neuropeptide Y Y2 receptor agonist in the bronchial circulation of anaesthetised dogs
34. A neuroendocrine reappraisal of the dual-centre hypothesis: Its implications for obesity and insulin resistance
35. The MONA LISA hypothesis. Most obesities known are low in sympathetic activity
36. Microtopography of the autonomic nerves in the rat knee: A fluorescence microscopic study
37. The development of autonomic innervation in bone and joints of the rat